CIK 0001851484 · <br>Emerging growth company
CITIUS ONCOLOGY, INC.
Sign in to watch- Ticker
- CTOR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 994362660
- Phone
- (908) 967-6677
- Business address
- 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD, NJ, 07016
- Former names
- TenX Keane Acquisition
- 8-K Event Material agreement
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 8-K/A Event Acquisition or sale completed
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change
- SC 13D Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Insider Changes in Ownership
Page 8 of 14 · 268 filings